MCM
CTSO icon

MAI Capital Management’s Cytosorbents Corp CTSO Stock Holding History

MAI Capital Management’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$132 Hold
233
– – ﹤0.01% 4704
2025
Q4 		$149 Hold
233
– – ﹤0.01% 4104
2025
Q3 		$218 Hold
233
– – ﹤0.01% 3702
2025
Q2 		$299 Hold
233
– – ﹤0.01% 3828
2025
Q1 		$233 Buy
233
+130
+126% +$137 ﹤0.01% 3304
2024
Q4 		$94 Buy
+103
New +$101 ﹤0.01% 3429

Other funds holding CTSO

AC
Avenir Corporation Alexandria, Virginia $820M AUM 2.4% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SC
Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

MAI Capital Management's CTSO Position: Q1 2026 in Review

MAI Capital Management held its Cytosorbents Corp (CTSO) position steady in Q1 2026 at 233 shares worth $132. The position accounts for ﹤0.01% of the portfolio, ranked #4704.

MAI Capital Management first reported a position in CTSO in Q4 2024 and has held it in 6 quarters since. The position peaked at $299 in Q2 2025. 50 funds tracked by Wall St. Rank hold CTSO as of Q1 2026.

  • MAI Capital Management held 233 shares of Cytosorbents Corp worth $132 as of Q1 2026.
  • MAI Capital Management left its Cytosorbents Corp share count unchanged in Q1 2026.
  • Cytosorbents Corp made up ﹤0.01% of MAI Capital Management's portfolio in Q1 2026, its #4704 holding.
  • MAI Capital Management first reported a position in Cytosorbents Corp in Q4 2024 and has held it in 6 quarters since.
  • MAI Capital Management's Cytosorbents Corp position peaked at $299 in Q2 2025.
  • 50 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q1 2026.

Based on MAI Capital Management's 13F filing for Q1 2026, filed 15 May 2026.